Q1 2025 Anupam Rasayan India Ltd Earnings Call Transcript
Key Points
- Pharma and polymer segments have shown strong growth, contributing 15% and 10% to revenue respectively.
- Investment in a hybrid power plant is expected to save approximately INR15 crores annually, moving towards energy net-zero by 2027.
- Significant traction in Japan and the US markets, with expectations of one-third of sales originating from Japan in the next two to three years.
- Successful commercialization of 12+ molecules in the last year, with multiple LOIs securing long-term contracts.
- Strategic focus on cost optimization and operational efficiency to achieve ESG goals and long-term growth.
- Consolidated operating revenue for the quarter saw a Y-o-Y degrowth of 34%, primarily due to lower volume offtake in the agrochemical segment.
- EBITDA margin decreased by over 5 percentage points to 23% in Q1 FY25 due to lower sales.
- Profit after tax dropped significantly to INR12 crores in Q1 FY25 from INR52 crores in Q1 FY24.
- Working capital remains high, with expectations of stabilization only by the end of FY26.
- Challenges in the agrochemical industry due to unwinding of channel inventories, expected to persist until the end of H1 FY25.
Ladies and gentlemen, good day, and welcome to the Q1 FY25 Earnings Conference Call of Anupam Rasayan India Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Krishna Patel from Ernst & Young. Thank you, and over to you, ma'am.
Thank you, Rituja, and good evening, everyone. Welcome to Anupam Rasayan India Limited's Q1 FY25 Earnings Call. Please note that a copy of the disclosure is available on the Investors section of the website as well as on the stock exchange. Anything said on this call, which reflects the outlook towards the future or which could be construed as a forward-looking statement must be reviewed in conjunction with the risk that the company faces.
Please note that the audio of the earnings call is the copyright material of Anupam Rasayan and cannot be copied, rebroadcasted, attributed in press or media without specific and written consent of the company. Today from the management side, we have with us with Mr. Anand Desai,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
